doxazosin has been researched along with Cognitive Decline in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Excerpt | Relevance | Reference |
---|---|---|
"Self-reported withdrawal symptoms also were negatively associated with time to smoking." | 2.87 | A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers. ( McKee, SA; Moore, KE; Oberleitner, LM; Roberts, W; Verplaetse, TL, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Roberts, W | 1 |
Verplaetse, TL | 1 |
Moore, KE | 1 |
Oberleitner, LM | 1 |
McKee, SA | 1 |
1 trial available for doxazosin and Cognitive Decline
Article | Year |
---|---|
A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Attention; Cognitive Dysfunction; Double-Blind Metho | 2018 |